Class IIDrug
Semaglutide 4.5mg recall
Summary
Apollo Care, LLC is recalling SEMAGLUTIDE 4.5mg (0.9 mg/mL) (drug). According to the FDA report, the reason is: Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material. The FDA rated this a Class II: the product may cause temporary or medically reversible health problems; serious harm is unlikely. Recall status: Ongoing.
Details from the FDA report
- Product
- SEMAGLUTIDE 4.5mg (0.9 mg/mL), 5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, 3801 Mojave Ct, Ste 102, Columbia, MO 65202. NDC 71170-812-03
- Reason
- Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material
- Lot / code info
- Lot: AC-017124, Exp. 8/30/2026; AC-017136, Exp. 12/31/2026.
- Quantity
- 9,762 vials.
- Distribution
- Nationwide within the U.S
- Recalling company
- Apollo Care, LLC, Columbia, MO United States
- Recall started
- July 29, 2026
- FDA report date
- August 19, 2026
- Classification
- Class II: The product may cause temporary or medically reversible health problems; serious harm is unlikely.
- Voluntary / mandated
- Voluntary: Firm initiated
- Status
- Ongoing
- Recall number
- D-0750-2026
What to do
- Check whether you have this product, and compare the lot numbers, codes, or dates on your package with the codes listed above.
- If it matches, stop using it and keep it away from children and pets.
- Contact the recalling company (Apollo Care, LLC) or the store where you bought it about returns or refunds.
- Do not stop a prescribed medication without first talking to your pharmacist or doctor; they can help find a safe replacement.
- If you think the product made you or someone else sick, contact a doctor or pharmacist. In an emergency call 911.
- You can report problems to the FDA via MedWatch.